Pregnancy and Childbirth in Women with Thalassemia Yesterday and Today
1 other identifier
observational
75
1 country
1
Brief Summary
Recent advances in the management of thalassemia have significantly improved life expectancy and quality of life of patients with this hemoglobinopathy, with a consequent increase in their reproductive potential and desire to have children.Since an initial report of a successful pregnancy in a woman with thalassemia major by Walker in 1969, hundreds of pregnancies have been reported so far, highlighting that women carefully managed in the preconception phase usually carry out a successful gestation and labor, both in case of spontaneous conception and assisted reproductive techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 14, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 14, 2024
CompletedFirst Submitted
Initial submission to the registry
March 17, 2025
CompletedFirst Posted
Study publicly available on registry
March 21, 2025
CompletedMarch 21, 2025
March 1, 2025
9 months
March 17, 2025
March 17, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
number of pregnancies in women with beta thalassemia followed in Italian centres
To evaluate the number of pregnancies in women with beta thalassemia followed in Italian centres and how the increase in the average age of the thalassemia population impact on the number of new pregnancies over time
15 YEARS
number of pregnancies spontaneously
many pregnancies occurred spontaneously
15 YEARS
number of pregnancies after hormonal stimulation
number of pregnancies after hormonal stimulation
15 YEARS
likelihood of miscarriage
To evaluate the likelihood of miscarriage
15 YEARS
foetal death
To evaluate foetal death
15 YEARS
Eligibility Criteria
FEMALE THALASSEMIE DEPEND TRANSFUSION
You may qualify if:
- Transfusion dependent and nontransfusion- dependent thalassemia
- Pregnancy ended with the birth of a live or dead foetus
- Pregnancy ended in miscarriage or voluntary abortion
- Pregnancy in progress
You may not qualify if:
- Other types of anemia
- Pregnancy not initiated despite assisted fertilization practices
- Subjects unwilling to sign informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UniversityCagliari, OspPed Microcitemico, Cagliari
Cagliari, CAGLIARI, 09123, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 17, 2025
First Posted
March 21, 2025
Study Start
August 9, 2023
Primary Completion
May 14, 2024
Study Completion
May 14, 2024
Last Updated
March 21, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share